Lyme disease cases in England rise by more than 20% in a year
Lyme disease cases in England have increased by over 20% in the past year, according to public health experts. The rise in cases has prompted pharmaceutical companies to develop new vaccines and treatments for the tick-borne illness. Factors such as awareness, testing rates, and outdoor activities are expected to influence case rates in the future.
- ▪There were 1,168 laboratory-confirmed cases of Lyme disease in 2025, up from 959 in 2024, marking a 22% increase.
- ▪Two probable cases of tick-borne encephalitis were identified in 2025, bringing the total to six since 2019.
- ▪The geographical distribution of ticks in the UK has been increasing in recent years due to various environmental factors.
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 2,394 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | World news | The Guardian |
| Canonical URL | https://www.theguardian.com/world/2026/may/21/lyme-disease-cases-england-rise-tick-vaccines |
| Publication time | Thu, 21 May 2026 09:13:52 GMT |
| Retrieval time | 2026-05-21T09:21:10.393Z |
| Last seen | 2026-05-21T09:51:55.292Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 3doLTJGNrkj3 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Symptoms of Lyme disease can include a bullseye-like rash and fever. Photograph: anakopa/Getty Images/iStockphotoView image in fullscreenSymptoms of Lyme disease can include a bullseye-like rash and fever. Photograph: anakopa/Getty Images/iStockphotoLyme diseaseLyme disease cases in England rise by more than 20% in a yearScientists developing vaccines and anti-tick treatments amid growing concern over spread of diseaseNicola Davis Science correspondentThu 21 May 2026 05.13 EDTLast modified on Thu 21 May 2026 05.19 EDTSharePrefer the Guardian on GoogleCases of Lyme disease have risen more than 20% in England in the past year, public health experts have revealed, as pharmaceutical companies work to create new vaccines and drugs to tackle the tick-borne illness.According to data from the UK…
Excerpt limited to ~120 words for fair-use compliance. The full article is at World news | The Guardian.
Discussion
0 commentsMore from World news | The Guardian
